Malignant pleural effusion: current understanding and therapeutic approach.

Authors:
Gonnelli F; Hassan W; Bonifazi M; Pinelli V; Bedawi EO and 3 more

Journal:
Respir Res

Publication Year: 2024

DOI:
10.1186/s12931-024-02684-7

PMCID:
PMC10797757

PMID:
38243259

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Respir Res

Abbreviation: Respir Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A combination of mild-moderate hypoxemia and low compliance is highly prevalent in persistent ARDS:…
Papoutsi E; Andrianopoulos I; Mavrikaki V and 8 more (2024) - Transparency Score: 3/6
Advancing accuracy in breath testing for lung cancer: strategies for improving diagnostic precision…
Chen KC; Kuo SW; Shie RH and 1 more (2024) - Transparency Score: 3/6
Associations between long-term ozone exposure and small airways function in Chinese young adults: a…
Feng S; Yang L; Dou S and 10 more (2024) - Transparency Score: 3/6
Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomiz…
Eltahan NH; Elsawy NH; Abdelaaty KM and 3 more (2024) - Transparency Score: 4/6
Bhlhe40 deficiency attenuates LPS-induced acute lung injury through preventing macrophage pyroptosi…
Hu X; Zou M; Zheng W and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot Applicable. Competing interestsFM serves as an Associate Editor on the Editorial Board of the Journal.The remaining authors have no conflict of interests to declare. Competing interests FM serves as an Associate Editor on the Editorial Board of the Journal.The remaining authors have no conflict of interests to declare."

Evidence found in paper:

"Funding None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025